Tower Research Capital LLC (Trc) Adicet Bio, Inc. Transaction History

Tower Research Capital LLC (Trc)

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.21 - $2.4 $39,321 - $77,992	32,497 Added 1103.46%	35,442 $42,000
Q1 2024 May 15, 2024	SELL	$1.76 - $3.45 $16,140 - $31,639	-9,171 Reduced 75.69%	2,945 $6,000
Q4 2023 Feb 13, 2024	BUY	$1.11 - $1.89 $1,343 - $2,286	1,210 Added 11.09%	12,116 $22,000
Q3 2023 Nov 14, 2023	SELL	$1.37 - $3.4 $556 - $1,380	-406 Reduced 3.59%	10,906 $14,000
Q2 2023 Aug 14, 2023	BUY	$2.13 - $7.13 $17,877 - $59,842	8,393 Added 287.53%	11,312 $27,000
Q1 2023 May 09, 2023	BUY	$5.52 - $9.23 $8,605 - $14,389	1,559 Added 114.63%	2,919 $17,000
Q4 2022 Feb 10, 2023	SELL	$7.72 - $21.27 $4,145 - $11,421	-537 Reduced 28.31%	1,360 $13,000
Q3 2022 Nov 10, 2022	BUY	$13.43 - $18.74 $6,218 - $8,676	463 Added 32.29%	1,897 $27,000
Q2 2022 Aug 15, 2022	SELL	$10.26 - $20.81 $61,488 - $124,714	-5,993 Reduced 80.69%	1,434 $21,000
Q1 2022 May 12, 2022	BUY	$11.53 - $19.97 $68,407 - $118,482	5,933 Added 397.12%	7,427 $148,000
Q4 2021 Feb 14, 2022	BUY	$7.37 - $17.49 $2,476 - $5,876	336 Added 29.02%	1,494 $26,000
Q3 2021 Nov 15, 2021	SELL	$6.29 - $9.93 $9,906 - $15,639	-1,575 Reduced 57.63%	1,158 $9,000
Q2 2021 Aug 16, 2021	BUY	$9.19 - $15.93 $2,352 - $4,078	256 Added 10.34%	2,733 $28,000
Q1 2021 May 17, 2021	BUY	$12.12 - $17.17 $20,955 - $29,686	1,729 Added 231.15%	2,477 $32,000
Q4 2020 Feb 16, 2021	SELL	$10.36 - $14.77 $16,265 - $23,188	-1,570 Reduced 67.73%	748 $11,000
Q3 2020 Nov 16, 2020	BUY	$10.18 - $21.4 $23,597 - $49,605	2,318 New	2,318 $28,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.